The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Sheeja NavakkodeJulietta Uta Frey

Abstract

We investigated the effects of rolipram, a selective cAMP phosphodiesterase (PDE) inhibitor, on late plastic events during functional CA1 plasticity in vitro in rat hippocampal slices. We present data showing that an early form of long-term potentiation (LTP) (early-LTP) that normally decays within 2-3 hr can be converted to a lasting LTP (late-LTP) if rolipram is applied during tetanization. This rolipram-reinforced LTP (RLTP) was NMDA receptor and protein synthesis dependent. cAMP formation in region CA1 during late-LTP requires dopaminergic receptor activity (Frey et al., 1989, 1990). Thus, we studied whether RLTP was influenced by inhibitors of the D(1)/D(5) receptor. Application of the specific D(1)/D(5) antagonist SCH23390 (0.1 microm) did not prevent RLTP, suggesting that the phosphodiesterase inhibitor acts downstream of the D(1)/D(5) receptors. We also studied whether rolipram can interact with processes of synaptic tagging, because RLTP was also dependent on protein synthesis, similar to late-LTP. Inhibition of PDE and subsequent induction of RLTP in one synaptic population were able to transform early-LTP into late-LTP in a second, independent synaptic population of the same neurons. This supports our hypothesis that...Continue Reading

Citations

Aug 19, 2008·Psychopharmacology·Olga A H ReneerkensJos Prickaerts
Jun 1, 2005·Behavioural Brain Research·Vanee PhoJames A Cherry
Jun 21, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Peng ZhongQing-Song Liu
Jul 1, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Barbara MontiAntonio Contestabile
Mar 25, 2011·Learning & Memory·Steven A ConnorPeter V Nguyen
Sep 4, 2008·Journal of Integrative Neuroscience·Bruce G Mockett, Sarah R Hulme
Mar 22, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·David J TitusColeen M Atkins
Feb 1, 2014·Neural Computation·Anca Rădulescu
May 13, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eva BollenJos Prickaerts
Apr 5, 2014·Cell Biochemistry and Biophysics·Sheng PengGuanglei Wang
Jul 26, 2013·Expert Opinion on Therapeutic Targets·Wito RichterMarco Conti
Feb 24, 2016·Frontiers in Systems Neuroscience·Nicole M WilsonColeen M Atkins
Feb 10, 2016·Frontiers in Molecular Neuroscience·Bing GongChristopher Cardozo
Feb 15, 2011·Pharmacology, Biochemistry, and Behavior·Alvin V TerryScott J Webster
Aug 19, 2007·The Journal of Physiology·Sreedharan SajikumarJulietta U Frey
May 30, 2006·Neurobiology of Aging·David A CostaHuntington Potter
Aug 16, 2008·The European Journal of Neuroscience·Kris RuttenTanya L Wallace
Sep 11, 2013·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Kim T Blackwell, Joanna Jedrzejewska-Szmek
Mar 5, 2014·Annals of Neurology·Roberta RicciarelliErnesto Fedele
Oct 4, 2015·Biochemical and Biophysical Research Communications·Masatoshi OhnishiAtsuko Inoue
Sep 12, 2006·Molecular and Cellular Neurosciences·Brikha R ShresthaAnna Dunaevsky
May 21, 2015·Reviews in the Neurosciences·Abdul-Karim AbbasLaurence Ris
Dec 4, 2004·The Journal of Clinical Investigation·Bing GongOttavio Arancio
Jan 30, 2013·Neuropharmacology·Thomas M Sanderson, Emanuele Sher
Aug 2, 2016·Nature Communications·Masanori NomotoKaoru Inokuchi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.